Spots Global Cancer Trial Database for stage iv uterine sarcoma
Every month we try and update this database with for stage iv uterine sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma | NCT00390234 | Fallopian Tube ... Female Reproduc... Ovarian Carcino... Ovarian Sarcoma Recurrent Ovari... Recurrent Uteri... Stage III Ovari... Stage III Uteri... Stage IV Ovaria... Stage IV Uterin... Uterine Carcino... Uterine Leiomyo... | ziv-aflibercept | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy in Treating Patients With Sarcoma of the Uterus | NCT00005643 | Endometrial Can... Sarcoma | pegylated lipos... | 21 Years - | GOG Foundation | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | NCT00002764 | Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide conventional su... | 16 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus | NCT00002546 | Sarcoma | cisplatin ifosfamide adjuvant therap... radiation thera... | 21 Years - 120 Years | GOG Foundation | |
| Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery | NCT01553539 | Bone Cancer Chondrosarcoma Clear Cell Sarc... Metastatic Oste... Ovarian Sarcoma Recurrent Adult... Recurrent Osteo... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin... | therapeutic ang... laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer | NCT00287885 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... Sarcoma Vaginal Cancer Vulvar Cancer | docetaxel | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer | NCT00112489 | Sarcoma | carboplatin paclitaxel | 18 Years - 120 Years | GOG Foundation | |
| Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma | NCT00082823 | Cancer | ziv-aflibercept | 18 Years - 120 Years | Regeneron Pharmaceuticals | |
| Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma | NCT00004066 | Ovarian Cancer Sarcoma Small Intestine... | filgrastim docetaxel gemcitabine hyd... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | NCT00550654 | Kidney Cancer Melanoma (Skin) Metastatic Canc... Ovarian Cancer Sarcoma Unspecified Adu... | questionnaire a... 3-dimensional c... hypofractionate... image-guided ra... tomotherapy | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity | NCT00003548 | Cancer | aminocamptothec... | 18 Years - | NYU Langone Health | |
| Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma | NCT00053794 | Endometrial Can... Sarcoma | perifosine | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | NCT00433407 | Breast Cancer Lung Cancer Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... | trastuzumab | - | Jonsson Comprehensive Cancer Center | |
| Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus | NCT00003128 | Sarcoma | filgrastim ifosfamide paclitaxel | 18 Years - | GOG Foundation | |
| Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus | NCT00003128 | Sarcoma | filgrastim ifosfamide paclitaxel | 18 Years - | GOG Foundation | |
| Chemotherapy in Treating Patients With Advanced Sarcoma | NCT00002526 | Ovarian Cancer Sarcoma | filgrastim doxorubicin hyd... ifosfamide | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus | NCT00002993 | Sarcoma | cisplatin doxorubicin hyd... mitomycin C | - | GOG Foundation | |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT01155258 | Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M... | temsirolimus vinorelbine dit... | 18 Years - | University of Southern California | |
| Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus | NCT00379145 | Sarcoma | trabectedin | 18 Years - 120 Years | GOG Foundation | |
| Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer | NCT00905658 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | therapeutic nut... standard follow... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer | NCT00087191 | Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga... | EF5 motexafin lutet... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract | NCT00003334 | Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma | paclitaxel pegylated lipos... | - 120 Years | NYU Langone Health | |
| Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma | NCT00101127 | Sarcoma | filgrastim pegfilgrastim docetaxel gemcitabine hyd... | 18 Years - | GOG Foundation | |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT01155258 | Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M... | temsirolimus vinorelbine dit... | 18 Years - | University of Southern California | |
| Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00003939 | Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine... | trabectedin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer | NCT00032162 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma | carboplatin pegylated lipos... | 18 Years - | AGO Study Group | |
| Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00041236 | Sarcoma | exatecan mesyla... | 15 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Thalidomide in Treating Patients With Gynecologic Sarcomas | NCT00006005 | Endometrial Can... Sarcoma | thalidomide | - | National Cancer Institute (NCI) | |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery | NCT01553539 | Bone Cancer Chondrosarcoma Clear Cell Sarc... Metastatic Oste... Ovarian Sarcoma Recurrent Adult... Recurrent Osteo... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin... | therapeutic ang... laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract | NCT00003334 | Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma | paclitaxel pegylated lipos... | - 120 Years | NYU Langone Health | |
| Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma | NCT00083213 | Cancer | ziv-aflibercept | 18 Years - 120 Years | Regeneron Pharmaceuticals | |
| Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus | NCT00033644 | Sarcoma | sargramostim cisplatin dacarbazine doxorubicin hyd... mitomycin C | 18 Years - | GOG Foundation | |
| Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer | NCT01098630 | Recurrent Cervi... Recurrent Uteri... Recurrent Uteri... Stage I Uterine... Stage I Uterine... Stage IA Cervic... Stage IB Cervic... Stage II Uterin... Stage II Uterin... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Uteri... Stage III Uteri... Stage IV Uterin... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... | Medical Chart R... Questionnaire A... | - | GOG Foundation | |
| Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma | NCT00033709 | Sarcoma | temozolomide thalidomide | 18 Years - | National Cancer Institute (NCI) | |
| Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy. | NCT00258401 | Cervical Cancer Diarrhea Prostate Cancer Radiation Toxic... Sarcoma | dietary interve... management of t... quality-of-life... | 20 Years - 80 Years | Case Comprehensive Cancer Center | |
| Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy. | NCT00258401 | Cervical Cancer Diarrhea Prostate Cancer Radiation Toxic... Sarcoma | dietary interve... management of t... quality-of-life... | 20 Years - 80 Years | Case Comprehensive Cancer Center | |
| Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00003939 | Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine... | trabectedin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer | NCT01132547 | Cancer | cyproheptadine ... placebo | 2 Years - 21 Years | University of South Florida | |
| Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer | NCT00003624 | Cervical Cancer Endometrial Can... Fallopian Tube ... Neurotoxicity Ovarian Cancer Primary Periton... Sarcoma | amifostine trih... cisplatin paclitaxel | - | GOG Foundation | |
| Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer | NCT00905658 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | therapeutic nut... standard follow... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00041236 | Sarcoma | exatecan mesyla... | 15 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma | NCT00004066 | Ovarian Cancer Sarcoma Small Intestine... | filgrastim docetaxel gemcitabine hyd... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma | NCT00410462 | Ovarian Cancer Sarcoma Small Intestine... | brostallicin doxorubicin hyd... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer | NCT00003624 | Cervical Cancer Endometrial Can... Fallopian Tube ... Neurotoxicity Ovarian Cancer Primary Periton... Sarcoma | amifostine trih... cisplatin paclitaxel | - | GOG Foundation | |
| Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer | NCT00383279 | Cervical Cancer Ovarian Cancer Sarcoma | counseling inte... study of socioe... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Chemotherapy in Treating Patients With Sarcoma of the Uterus | NCT00005643 | Endometrial Can... Sarcoma | pegylated lipos... | 21 Years - | GOG Foundation | |
| Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | NCT00550654 | Kidney Cancer Melanoma (Skin) Metastatic Canc... Ovarian Cancer Sarcoma Unspecified Adu... | questionnaire a... 3-dimensional c... hypofractionate... image-guided ra... tomotherapy | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer | NCT00055705 | Cancer | PV701 | 18 Years - | National Cancer Institute (NCI) | |
| Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity | NCT00003548 | Cancer | aminocamptothec... | 18 Years - | NYU Langone Health | |
| Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer | NCT00112489 | Sarcoma | carboplatin paclitaxel | 18 Years - 120 Years | GOG Foundation | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | NCT00002764 | Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide conventional su... | 16 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma | NCT00227669 | Sarcoma | docetaxel gemcitabine hyd... | 18 Years - 120 Years | UNICANCER | |
| Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma | NCT00082823 | Cancer | ziv-aflibercept | 18 Years - 120 Years | Regeneron Pharmaceuticals | |
| Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery | NCT00842452 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | topotecan hydro... pharmacological... | 18 Years - | Case Comprehensive Cancer Center | |
| Thalidomide in Treating Patients With Gynecologic Sarcomas | NCT00006005 | Endometrial Can... Sarcoma | thalidomide | - | National Cancer Institute (NCI) | |
| Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma | NCT00003778 | Ovarian Cancer Sarcoma | dolastatin 10 | 18 Years - | National Cancer Institute (NCI) | |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors | NCT00499291 | Cancer | paclitaxel albu... gene expression... laboratory biom... pharmacological... polymerase chai... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus | NCT00033644 | Sarcoma | sargramostim cisplatin dacarbazine doxorubicin hyd... mitomycin C | 18 Years - | GOG Foundation | |
| Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma | NCT00245102 | Adult Angiosarc... Adult Epithelio... Adult Leiomyosa... Adult Malignant... Adult Neurofibr... Adult Synovial ... Ovarian Sarcoma Recurrent Adult... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin... Uterine Carcino... Uterine Leiomyo... | sorafenib tosyl... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
